City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Auayporn Nademanee, MD  
Search results:  2  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-2 Trials Jump to page:

COH Protocol Number: 16349

Principal Investigator: Auayporn Nademanee, MD
Sponsor: Institutional

Title:  Single Patient IND for JE of Open-label Midostaurin in a Patient with Agressive Systemic Mastocytosis

COH Protocol Number: 02149 ClinicalTrials.gov Number: NCT01166009

Principal Investigator: Auayporn Nademanee, MD
Sponsor: Institutional

Title:  NMDP 2002-0063: Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

 
Results per page: 25 50 100 All 1-2 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.